3KY fundamentals
An in-depth look to HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED operating, investing, and financing activities
3KY free cash flow for H2 23 is 259.84 M EUR. For 2023, 3KY free cash flow was 439.99 M EUR and operating cash flow was 468.14 M EUR.
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: EUR
TTM